cdk4 glutathione Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer Cyclin D-Cdk4,6 Drives Cell-Cycle Progression
Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix PMC Targeting CDK4 6 for Anticancer Therapy cdk4 glutathione CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets Cyclin D1Cdk4 controls glucose metabolism Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



